<h1 align="center">CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment</h1>

Meenakshi Kar (1,2,3), Katherine E.E. Johnson (4), Abigail Vanderheiden (5,6), Elizabeth J. Elrod (2,3,7), Katharine Floyd (1,2,3), Elizabeth Geerling (8), E. Taylor Stone (8), Eduardo Salinas (2,3,7), Stephanie Banakis (4) Wei Wang (4), Shruti Sathish (4), Swathi Shrihari (1,2,3), Meredith E. Davis-Gardner (1,2,3), Jacob Kohlmeier (9), Amelia Pinto (8), Robyn Klein (5,6,10,11), Arash Grakoui (2,3,12), Elodie Ghedin (4), Mehul S. Suthar (1,2,3,9)

1. Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. 
2. Emory Vaccine Center, Emory University, Atlanta, GA, USA.
3. Emory National Primate Research Center, Atlanta, GA, USA.
4. Systems Genomics Section, Laboratory of Parasitic Diseases, DIR, NIAID, NIH, Bethesda, Maryland, USA.
5. Center for Neuroimmunology and Neuroinfectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.
6. Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
7. Department of Medicine, Emory University School of Medicine, Emory University, Atlanta, GA, USA.
8. Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, MO, USA.
9. Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA.
10. Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA
11. Department of Neurosciences, Washington University School of Medicine, St. Louis, MO, USA
12. Department of Medicine, Emory University School of Medicine, Emory University, Atlanta, GA, USA.

[bioRxiv link](https://www.biorxiv.org/content/10.1101/2024.01.23.576505v1)

Zenodo DOI: 10.5281/zenodo.12537008
